[Dosage forms in Parkinson treatment].
Riebesehl
Bernd
B
Lilly Forschung GmbH, Hamburg. RIEBESEHL_BERND@LILLY.COM
Lipp
Ralph
R
D000978:Antiparkinson Agents / Q000008:administration & dosage* / Q000627:therapeutic use*; D003692:Delayed-Action Preparations; D004304:Dosage Forms; D016503:Drug Delivery Systems; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy*
D000978:Antiparkinson Agents; D003692:Delayed-Action Preparations; D004304:Dosage Forms; D007980:Levodopa